Impact of body mass index on fasting blood glucose concentration among Helicobacter pylori carriers

Digestive Diseases

Volumn 21, Issue 3, 2003, Pages 262-265

  Kyriazanos, Ioannis D ^a,b   Sfiniadakis, Ioannis ^a   Dimakos, Panagiotis ^a   Gizaris, Vasilios ^a   Datsakis, Konstantinos ^a   Dafnopoulou, Aggeliki ^a  

^a ATHENS NAVAL HOSPITAL   (Greece)

^b NONE   (Greece)

Author keywords

Body mass index; Fasting blood glucose levels; Helicobacter pylori; Obesity

Indexed keywords

CREATININE; GLUCOSE; IMMUNOGLOBULIN G ANTIBODY; UREA; URIC ACID;

ADULT; ARTICLE; BACTERIUM CARRIER; BODY MASS; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; GASTROSCOPY; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE TEST; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; NAVY; OBESITY; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; STOMACH BIOPSY;

ADULT; ANTIBODIES, BACTERIAL; BLOOD GLUCOSE; BODY MASS INDEX; ENZYME-LINKED IMMUNOSORBENT ASSAY; FASTING; GASTROSCOPY; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MALE; MILITARY PERSONNEL; OBESITY; RISK FACTORS;

EID: 0142218872     PISSN: 02572753     EISSN: None     Source Type: Journal    
DOI: 10.1159/000073345     Document Type: Article

References (22)

1. Senturk O, Canturk Z, Cetinarslan B, Ercin C, Hulagu S, Canturk NZ: Prevalence and comparison of five different diagnostic methods for Helicobacter pylori in diabetic patients. Endocr Res 2001;27:179-189.
2. De Luis DA, Cordero JM, Caballero C, Boixeda D, Aller C, Canton R, De la Calle H: Effect of the treatment of Helicobacter pylori infection on gastric emptying and its influence on the glycaemic control in type 1 diabetes mellitus. Diabetes Res Clin Pract 2001;52:1-9.
3. Peach HG, Barnett NE: Helicobacter pylori infection and fasting plasma glucose concentration. J Clin Pathol 2001;54:446-449.
4. Kyriazanos ID, Sfiniadakis I, Gizaris V, Hountis P, Hatziveis K, Dafnopoulou A, Datsakis K: The incidence of Helicobacter pylori infection is not increased among obese young individuals in Greece. J Clin Gastroenterol 2002;34:541-546.
5. NIH: Clinical Guidelines on the Identification, Evaluation and Treatment of Overweight and Obesity in Adults. Bethesda, NIH, 1998. www.nhlbi.nih.gov/ guidelines
6. Van Den Brink GR, ten Kate FJ, Ponsioen CY, Rive MM, Tytgat GN, van Deventer SJ, Peppelenbosch MP: Expression and activation of the NF-κB in the antrum of the human stomach. J Immunol 2000;164:3353-3359.
7. Rose S: Gastrointestinal and Hepatobilliary Pathophysiology. Philadelphia, Fence Creek Publishing, 1998, pp 161-172.
8. Calam J, Gibbons A, Haley Z, Bliss P, Arebi N: How does Helicobacter pylori cause mucosal damage? Its effect on acid and gastrin physiology. Gastroenterology 1997;113:S43-S49.
9. Acbay O, Celik AF, Gundogdu S: Does Helicobacter pylori-induced gastritis enhance food-stimulated insulin release? Dig Dis Sci 1996;41:1327-1331.
10. Landsberg L, Krieger DR: Obesity, metabolism and the sympathetic nervous system. Am J Hypertens 1989;2:125S-132S.
11. Acbay O, Celik AF, Kadioglu P, Goksel S, Gundogdu S: Helicobacter pylori-induced gastritis may contribute to occurrence of postprandial symptomatic hypoglycemia. Dig Dis Sci 1999;44:1837-1842.
12. Perdichizzi G, Bottari M, Pallio S, Fera MT, Carbone M, Barresi G: Gastric infection by Helicobacter pylori and antral gastritis in hyperglycemic obese and in diabetic subjects. New Microbiol 1996;19:149-154.
13. Begue RE, Mirza A, Compton T, Gomez R, Vargas A: Helicobacter pylori infection and insulin requirement among children with type 1 diabetes mellitus. Pediatrics 1999;103:e83.
14. Zimmet P, Hodge A, Nicolson M, Staten M, de Courten M, Moore J, Morawiecki A, Lubina J, Collier G, Alberti G, Dowse G: Serum leptin concentration, obesity and insulin resistance in Western Samoans: Cross-sectional study. BMJ 1996;313:965-969.
15. Janeckowa R: The role of leptin in human physiology and pathophysiology. Physiol Res 2001;50:443-459.
16. Mantzoros CS: The role of leptin in human obesity and disease: A review of current evidence. Ann Intern Med 1999;130:671-680.
17. Wolf G, Chen S, Han DC, Ziyadeh FN: Leptin and renal disease. Am J Kidney Dis 2002;39:1-11.
18. Fried SK, Ricci MR, Russell CD, Laferrere B: Regulation of leptin production in humans. J Nutr 2000;130:3127S-3131S.
19. Rasmussen MH, Hvidberg A, Juul A, Main KM, Gotfredsen A, Skakkebaek NE, Hilsted J: Massive weight loss restores 24-hour growth hormone release profiles and serum insulin-like growth factor-I levels in obese subjects. J Clin Endocrinol Metab 1995;80:2446.
20. Larsson H, Elmstahl S, Ahren B: Plasma leptin levels correlate to islet function independently of body fat in postmenopausal women. Diabetes 1996;45:1580-1584.
21. Sorensen IT, Echwald MS, Holm JC: Leptin in obesity. BMJ 1996;313:953-954.
22. Clement K, Lahlou N, Ruiz J, Hager J, Bougneres P, Basdevant A, Guy-Grand B, Froguel P: Association of poorly controlled diabetes with low serum leptin in morbid obesity. Int J Obes Relat Metab Disord 1997;21:556-561.